Priscila Grecca Pedrão

Mrs. Priscila Grecca Pedrão

Hospital de Câncer de Barretos, Barretos, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Priscila Grecca PedrãoPriscila Grecca Pedrão
Priscila Grecca Pedrão
YGYasmin Medeiros Guimarães
Yasmin Medeiros Guimarães
LGLuani Godoy
Luani Godoy
Júlio César Possati-ResendeJúlio César Possati-Resende
Júlio César Possati-Resende
ABAdriane Cristina Bovo
Adriane Cristina Bovo
RRRicardo Dos Reis
Ricardo Dos Reis
Vulvar cancer is a rare gynecological malignancy since it represents 4% of all cancers of the female genital tract. The most common histological type is squamous cell carcinoma (90%). This type can be classified into two clinicopathological subtypes according to the etiology. The first subtype is associated with persistent human papillomavirus infection and is usually diagnosed in younger women. The second subtype is associated with lichen sclerosus condition, and in most cases is diagnosed in postmenopausal women. Currently, an increase in first subtype cases has been observed, which raised the concern about associated mortality and treatment morbidity among young women. Vulvar cancer treatment depends on histopathology grade and staging, but surgery with or without radiotherapy as adjuvant treatment is considered the gold standard. In recent decades, sentinel lymph node biopsy has been incorporated as part of the treatment. Therefore, we sought to review and discuss the advances documented in the literature about vulvar cancer focusing on the treatment of early-stage disease. Relevant articles, such as the GROINS-V studies and the GOG protocols, are presented in this review. Additionally, we discuss key points such as the evolution of treatment from invasive surgery with high morbidity, to more conservative approaches without compromising oncologic safety; the role of sentinel lymph node mapping in the initial staging, since it reduces the complications caused by inguinofemoral lymphadenectomy; the recurrences rates, since local recurrence is common and curable, however, groin-associated, or distant recurrences have a poor prognosis; and, finally, the long-term follow-up that is essential for all patients.

18 February 2024 in Cancers
Verified
Journal Article
Open access
PDF file
AUAna Carla Franco Ubinha
Ana Carla Franco Ubinha
Priscila Grecca PedrãoPriscila Grecca Pedrão
Priscila Grecca Pedrão
ATAline Cássia Tadini
Aline Cássia Tadini
RSRonaldo Luis Schmidt
Ronaldo Luis Schmidt
MSMarcelo Henrique dos Santos
Marcelo Henrique dos Santos
RRRicardo Dos Reis
Ricardo Dos Reis
Pelvic exenteration represents a radical procedure aimed at achieving complete tumor resection with negative margins. Although it is the only therapeutic option for some cases of advanced tumors, it is associated with several perioperative complications. We believe that careful patient selection is related to better oncologic outcomes and lower complication rates. The objectives of this review are to identify the most current indications for this intervention, suggest criteria for case selection, evaluate recommendations for perioperative care, and review oncologic outcomes and potential associated complications. To this end, an analysis of English language articles in PubMed was performed, searching for topics such as the indication for pelvic exenteration for recurrent gynecologic neoplasms selection of oncologic cases, the impact of tumor size and extent on oncologic outcomes, preoperative and postoperative surgical management, surgical complications, and outcomes of overall survival and recurrence-free survival.

1 January 2017 in Aquatic Toxicology
Verified
Journal Article
Closed access
MPMarcelo Paulino
Marcelo Paulino
DTD. Tavares
D. Tavares
FBF. Bieczynski
F. Bieczynski
Priscila Grecca PedrãoPriscila Grecca Pedrão
Priscila Grecca Pedrão
NSN.E.S. Souza
N.E.S. Souza
MFM.N. Fernandes
M.N. Fernandes

25 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
LGLuani Godoy
Luani Godoy
Júlio César Possati-ResendeJúlio César Possati-Resende
Júlio César Possati-Resende
YGYasmin Medeiros Guimarães
Yasmin Medeiros Guimarães
Priscila Grecca PedrãoPriscila Grecca Pedrão
Priscila Grecca Pedrão
RRRicardo Dos Reis
Ricardo Dos Reis
ALAdhemar Longatto-Filho
Adhemar Longatto-Filho
Cervical cancer is caused by HPV. Although it is the fourth most common type of cancer diagnosed and the fourth cause of cancer death, cervical cancer is nearly completely preventable because of the vaccination and screening available. The present review aims to map the initiatives conducted to implement or evaluate the implementation of HPV testing in Latin American countries. We performed the review by searching on PubMed in the English language and on grey literature, as most of the information about the guidelines used was found in governmental websites in the Spanish language. We only found information in eight countries concerning HPV testing as primary screening. Only Mexico has established HPV-based screening in all territories. There are three countries with regional implementation. Two countries with pilot studies indicated results that supported implementation. Finally, there are another two countries with a national recommendation. We have learned that HPV implementation is feasible and a very promising tool for reducing cervical cancer morbidity and mortality. The costs associated with saving lives and reducing suffering due to morbidity of a preventable disease must be pragmatically evaluated by the Latin America governments, and improving outcomes must be a mandatory priority for those that are responsible for addressing an organized system of cervical cancer screening.

8 October 2024 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
MTMilena Roberta Teixeira
Milena Roberta Teixeira
GOGabriela da Silva Oliveira
Gabriela da Silva Oliveira
CACarlos Eduardo Mattos Cunha Andrade
Carlos Eduardo Mattos Cunha Andrade
RSRonaldo Luis Schmidt
Ronaldo Luis Schmidt
VTValiana Alves Teodoro
Valiana Alves Teodoro
RRRicardo Dos Reis
Ricardo Dos Reis

5 May 2021 in Acta Cytologica
Verified
Journal Article
Closed access
PDF file
Priscila Grecca PedrãoPriscila Grecca Pedrão
Priscila Grecca Pedrão
ACAna Carolina de Carvalho
Ana Carolina de Carvalho
JPJúlio César Possati-Resende
Júlio César Possati-Resende
FCFernanda de Paula Cury
Fernanda de Paula Cury
NCNathália C. Campanella
Nathália C. Campanella
JFJosé Humberto T.G. Tavares Guerreiro Fregnani
José Humberto T.G. Tavares Guerreiro Fregnani
Introduction: Alternative methods of dry storage and transportation may be a viable alternative to the use of liquid storage medium for cervical samples, especially for screening programs in places with few resources. Objective: The objective of this study is to verify the viability and efficacy of human papillomavirus DNA (HPV-DNA) detection in cervical cell samples collected and stored on a Flinders Technology Associates (FTA) card (Whatman Indicating FTA® Elute Micro Card) and subsequently recovered in ethanol-based liquid medium and to compare the results to those obtained using samples stored directly in ethanol-based liquid medium. Study Design: Thirty-four women submitted to ETZ (excision of the transformation zone of the cervix) were included in this study. Before ETZ, 2 samples of exfoliated cervical cells were collected from each woman by a doctor and stored in ethanol-based liquid medium and on an FTA card. DNA recovery from FTA samples was performed using ethanol-based liquid medium. Detection of HPV-DNA in the samples was performed using the Cobas® 4800 HPV Test Platform. Results and Conclusions: The HPV-DNA detection positivity rates were 70.6% for the samples collected directly in liquid medium and 64.7% for the samples stored on the FTA card, with high detection accuracy in the DNA samples recovered from the FTA card (area under the curve = 0.958; 95% confidence interval = 0.890–1.000). The concordance between the results obtained using the 2 storage media was 94.1% (Kappa = 0.866). These preliminary results suggest that collection of cervical material on an FTA card may be an alternative to storage in liquid medium since the liquid medium has some limitations. In addition, DNA recovery from the card using ethanol-based liquid medium streamlines the workflow in the laboratory and reduces the cost associated with reagents, thereby facilitating access to the HPV test in places with few resources and potentially improving cervical cancer screening.